Update on the management of ovarian germ cell tumors

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 50, Issue 6, 2005, Pages 417-425

  Lu, Karen H ^a   Gershenson, David M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chemotherapy; Germ cell tumor; Ovarian cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; TUMOR MARKER; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CONFERENCE PAPER; DECISION MAKING; DYSGERMINOMA; FERTILITY; GERM CELL TUMOR; HUMAN; OVARY CANCER; OVARY TERATOMA; OVARY TUMOR; PRIMORDIAL GERM CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FERTILITY; GERMINOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; TREATMENT OUTCOME;

EID: 20844440915     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (54)

1. Gershenson DM: Update on malignant ovarian germ cell tumors. Cancer 1993;71:1581-1590
2. Williams SD, Horowitz CJ, Silva E: Ovarian germ-cell tumors. In Principles and Practice of Gynecologic Oncology. Edited by WJPC Hoskins, RC Young. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 1059-1074
3. Williams SWL, Ngan HYS: Management of ovarian germ cell tumors. In Ovarian Cancer Controversies in Management. Edited by DM Gershenson. New York, Churchill Livingstone, 1998, pp 399-416
4. Albrektsen G, Heuch I, Kvale G: Full-term pregnancies and incidence of ovarian cancer of stromal and germ cell origin: A Norwegian prospective study. Br J Cancer 1997;75:767-770
5. Young JL Jr, Cheng Wu X, Roffers SD, et al: Ovarian cancer in children and young adults in the United States, 1992-1997. Cancer 2003;97:2694-2700
6. Serov SF, Sobin LJ: Histological Typing of Ovarian Tumors. Geneva, World Health Organization, 1973
7. Talerman A: Germ cell tumors of the ovary. In Blaustein's Pathology of the Female Genital Tract. Edited by RJ Kurman. New York, Springer, 2002, pp 967-1034
8. Hart WR, Burkons DM: Germ cell neoplasms arising in gonadoblastomas. Cancer 1979;43:669-678
9. Pierga JY, Giacchetti S, Vilain E, et al: Dysgerminoma in a pure 45,X Turner syndrome: Report of a case and review of the literature. Gynecol Oncol 1994;55:459-464
10. Gershenson DM, Del Junco G, Herson J, et al: Endodermal sinus tumor of the ovary: The M. D. Anderson experience. Obstet Gynecol 1983;61:194-202
11. Kurman RJ, Norris HJ: Endodermal sinus tumor of the ovary: A clinical and pathologic analysis of 71 cases. Cancer 1976;38:2404-2419
12. Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary: A clinical and pathologic study of 58 cases. Cancer 1976;37:2359-2372
13. O'Connor DM, Norris HJ: The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. Int J Gynecol Pathol 1994;13: 283-289
14. Kurman RJ, Norris HJ: Malignant mixed germ cell tumors of the ovary. A clinical and pathologic analysis of 30 cases. Obstet Gynecol 1976;48:579-589
15. Gershenson DM, Del Junco G, Copeland LJ, et al: Mixed germ cell tumors of the ovary. Obstet Gynecol 1984;64:200-206
16. Schwartz PE, Morris JM: Serum lactic dehydrogenase: A tumor marker for dysgerminoma. Obstet Gynecol 1988;72: 511-515
17. Fujii S, Konishi I, Suzuki A, et al: Analysis of serum lactic dehydrogenase levels and its isoenzymes in ovarian dysgerminoma. Gynecol Oncol 1985;22:65-72
18. Pressley RH, Muntz HG, Falkenberry S, et al: Serum lactic dehydrogenase as a tumor marker in dysgerminoma. Gynecol Oncol 1992;44:281-283
19. Slayton RE, Park RC, Silverberg SG, et al: Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary: A Gynecologic Oncology Group Study (a final report). Cancer 1985;56:243-248
20. Williams SD, Blessing JA, Moore DH, et al: Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors: A trial of the Gynecologic Oncology Group. Ann Intern Med 1989;111:22-27
21. Gershenson DM, Copeland LJ, del Junco G, et al: Second-look laparotomy in the management of malignant germ cell tumors of the ovary. Obstet Gynecol 1986;67:789-793
22. Williams SD, Blessing JA, DiSaia PJ, et al. Second-look laparotomy in ovarian germ cell tumors: The Gynecologic Oncology Group experience. Gynecol Oncol 1994;52:287-291
23. Thomas GM, Dembo AJ, Hacker NF, et al: Current therapy for dysgerminoma of the ovary. Obstet Gynecol 1987;70:268-275
24. Cushing BS, Hite R: Effects of estradiol on sexual receptivity, wheel-running behavior, and vaginal estrus in virgin prairie voles. Physiol Behav 1996;60:829-832
25. Wong LC, Ngan HY, Ma HK: Primary treatment with vincristine, dactinomycin, and cyclophosphamide in nondysgerminomatous germ cell tumor of the ovary. Gynecol Oncol 1989;34:155-158
26. Gershenson DM, Copeland LJ, Kavanagh JJ, et al: Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamide. Cancer 1985;56:2756-2761
27. Carlson RW, Sikic BI, Turbow MM, et al: Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary. J Clin Oncol 1983; 1:645-651
28. Taylor MH, Depetrillo AD, Turner AR: Vinblastine, bleomycin, and cisplatin in malignant germ cell tumors of the ovary. Cancer 1985;56:1341-1349
29. Gershenson DM, Kavanagh JJ, Copeland LJ, et al: Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatin. Cancer 1986;57:1731-1737
30. Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987;316:1435-1440
31. Gershenson DM, Morris M, Cangir A, et al: Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 1990;8:715-720
32. Pedersen-Bjergaard J, Daugaard G, Hansen SW, et al: Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet 1991;338:359-663
33. Nichols CR, Breeden ES, Loehrer PJ, et al: Secondary leukemia associated with a conventional dose of etoposide: Review of serial germ cell tumor protocols. J Natl Cancer Inst 1993;85:36-40
34. Cushing B, Giller R, Ablin A, et al: Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: A report of the pediatric oncology group and the children's cancer group. Am J Obstet Gynecol 1999;181:353-358
35. Dark GG, Bower M, Newlands ES, et al. Surveillance policy for stage I ovarian germ cell tumors. J Clin Oncol 1997;15: 620-624
36. Williams S, Blessing JA, Liao SY, et al: Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: A trial of the Gynecologic Oncology Group. J Clin Oncol 1994;12:701-706
37. Williams SD, Blessing JA, Hatch KD, et al: Chemotherapy of advanced dysgerminoma: Trials of the Gynecologic Oncology Group. J Clin Oncol 1991;9:1950-1955
38. Loehrer PJ Sr, Johnson D, Elson P, et al: Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Cooperative Oncology Group trial. J Clin Oncol 1995;13:470-476
39. Bajorin DF, Sarosdy MF, Pfister DG, et al: Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multiinstitutional study. J Clin Oncol 1993;11:598-606
40. Messing MJ, Gershenson DM, Morris M, et al: Primary treatment failure in patients with malignant ovarian germ cell neoplasms. Int J Gynecol Cancer 1992;2:295-300
41. Loehrer PJ Sr, Lauer R, Roth BJ, et al: Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 1988;109:540-546
42. Nichols CR, Andersen J, Lazarus HM, et al: High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: An Eastern Cooperative Oncology Group protocol. J Clin Oncol 1992;10:558-563
43. Broun ER, Nichols CR, Turns M, et al: Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support. Cancer 1994;73:1716-1720
44. Broun ER, Nichols CR, Kneebone P, et al: Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 1992;117:124-128
45. Kollmannsberger C, Rick O, Derigs HG, et al: Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: A study of the German Testicular Cancer Study Group. J Clin Oncol 2002;20:2031-2037
46. Bokemeyer C, Beyer J, Metzner B, et al: Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. Ann Oncol 1996;7:31-34
47. Motzer RJ, Bajorin DF, Schwartz LH, et al: Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J Clin Oncol 1994;12:2277-2283
48. Bokemeyer C, Gerl A, Schoffski P, et al: Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. J Clin Oncol 1999;17:512-516
49. Einhorn LH, Stender MJ, Williams SD: Phase II trial of gemcitabine in refractory germ cell tumors. J Clin Oncol 1999;17: 509-511
50. Munkarah A, Gershenson DM, Levenback C, et al: Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol 1994;55:217-223
51. Brewer M, Gershenson DM, Herzog CE, et al: Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol 1999;17:2670-2675
52. Low JJ, Perrin LC, Crandon AJ, et al: Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors: A review of 74 cases. Cancer 2000;89: 391-398
53. Zanetta G, Bonazzi C, Cantu M, et al: Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 2001;19:1015-1020
54. Tangir J, Zelterman D, Ma W, et al: Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol 2003;101:251-257